Skip to main content

Omnio AB

omnio.se

Omnio AB develops recombinant plasminogen therapeutics specifically for the treatment of diabetic foot ulcers (DFUs). This approach aims to enhance wound healing and reduce the risk of complications associated with DFUs.

Traction 8/10
HQ unknown
Founded 20249500+ followers
  • Biotechnology
Updated 6 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Tor Ny

Founder of Omnio AB

Product

Features

  • Omnio AB develops recombinant plasminogen therapeutics specifically for the treatment of diabetic foot ulcers (DFUs). This approach aims to enhance wound healing and reduce the risk of complications associated with DFUs.
1
This profile is AI-generated and may contain inaccuracies.